Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Crack Down On GMP Ingredient, Contaminant Spec Requirements

This article was originally published in The Tan Sheet

Executive Summary

GMP inspectors will begin more aggressively enforcing requirements for ingredient and contaminant specifications, FDA’s Fabricant warns. Recalls for undeclared allergens, salmonella and other pathogens are emerging more frequently as well.

Advertisement

Related Content

More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
FDA Will Peel Back Another Layer Of GMP Compliance In 2013
FDA Will Peel Back Another Layer Of GMP Compliance In 2013
FDA Signals Progress In War On Adulterated Supplements
Spiked “Supplements” For Diabetes, Pain On The Rise
Basic GMP Failures Will Prompt Heightened FDA Scrutiny
FDA Revision Of NDI Draft Guidance Starts With Grandfathered List
Supplement Firms Should Test For Salmonella, Scientist Advises
FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements

Topics

Advertisement
UsernamePublicRestriction

Register

PS106098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel